Tag: US Food and Drug Administration

March 11, 2020

Analyst Lowers BridgeBio Price Target After Debt Issuance

George Farmer told investors that BMO Capital Markets is lowering its price target for BridgeBio Pharma to US$46, down from...
March 9, 2020

8 Small Biotech ETFs

Want to invest in small biotech ETFs? Here we profile eight that life science investors may want to look into.
March 5, 2020

Urovant Receives FDA Clearance of NDA for Bladder Treatment

The FDA has accepted for review the company’s New Drug Application (NDA) for its treatment of patients with overactive bladder.
March 3, 2020

Psychedelics Listing Makes Debut on the NEO

Mind Medicine made its official public debut on the NEO Exchange, becoming the first psychedelics medicine firm on the up...
February 26, 2020

What is Genetics Investing?

Genetics investing drives research that may ultimately prevent major illnesses. That makes it one of the most important life science...
February 20, 2020

How Do Medical Devices Get Approved?

How do medical devices get approved? INN breaks down the FDA's intricate process for classifying and regulating these products in...
February 19, 2020

Why Consider Investing in Pharmaceutical Stocks?

The pharmaceutical market is expected to increase in value, meaning there are plenty of opportunities for investing in pharmaceutical stocks.